Sale!

CACNA1D Gene Primary Aldosteronism Seizures and Neurologic Abnormalities NGS Genetic DNA Test

Original price was: $700.Current price is: $500.

-29%

The CACNA1D Gene Test is a comprehensive genetic analysis that identifies mutations in the CACNA1D gene associated with primary aldosteronism, seizures, and various neurologic abnormalities. This Next-Generation Sequencing (NGS) test provides crucial diagnostic information for patients experiencing unexplained hypertension, electrolyte imbalances, and neurological symptoms. By detecting specific genetic variants, the test helps guide targeted treatment strategies and provides valuable insights for family planning. The test costs $500 USD and offers significant benefits for individuals with complex endocrine and neurological presentations, enabling precise diagnosis and personalized medical management.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

CACNA1D Gene Primary Aldosteronism Seizures and Neurologic Abnormalities NGS Genetic DNA Test

Understanding the CACNA1D Gene Test

The CACNA1D Gene Test represents a cutting-edge diagnostic tool in genetic medicine, specifically designed to identify mutations in the CACNA1D gene that are responsible for complex medical conditions including primary aldosteronism, seizures, and various neurologic abnormalities. This comprehensive genetic analysis utilizes Next-Generation Sequencing (NGS) technology to provide precise and reliable results that can significantly impact patient care and treatment outcomes.

What Does the CACNA1D Gene Test Measure?

This advanced genetic test specifically targets and analyzes the CACNA1D gene, which encodes the alpha-1D subunit of voltage-gated calcium channels. These channels play a critical role in regulating calcium entry into cells, particularly in adrenal gland tissues and neuronal cells. The test detects:

  • Pathogenic variants associated with primary aldosteronism
  • Mutations linked to seizure disorders and epilepsy
  • Genetic abnormalities causing neurologic manifestations
  • Specific nucleotide changes affecting calcium channel function
  • Inherited and de novo mutations in the CACNA1D gene

Who Should Consider This Test?

This genetic test is particularly valuable for individuals presenting with specific clinical symptoms and family history patterns:

Clinical Indications and Symptoms

  • Patients with early-onset hypertension resistant to conventional treatment
  • Individuals with unexplained hypokalemia (low potassium levels)
  • Patients diagnosed with primary aldosteronism without clear cause
  • Individuals experiencing recurrent seizures or epilepsy of unknown origin
  • Patients with developmental delays and neurologic abnormalities
  • Those with family history of endocrine or neurological disorders
  • Children with congenital adrenal abnormalities
  • Patients with complex metabolic and neurological presentations

Benefits of CACNA1D Genetic Testing

Undergoing the CACNA1D gene test provides numerous advantages for patients and healthcare providers:

Diagnostic and Clinical Benefits

  • Precise Diagnosis: Provides definitive genetic confirmation of CACNA1D-related disorders
  • Personalized Treatment: Enables targeted therapy based on specific genetic findings
  • Family Planning: Offers valuable information for genetic counseling and reproductive decisions
  • Early Intervention: Facilitates timely management of endocrine and neurological symptoms
  • Comprehensive Assessment: Integrates genetic information with clinical presentation for holistic care
  • Research Contribution: Contributes to ongoing understanding of calcium channel disorders

Understanding Your Test Results

Interpreting CACNA1D gene test results requires specialized medical expertise:

Result Interpretation Guidelines

  • Positive Result: Indicates presence of pathogenic CACNA1D mutation, confirming genetic diagnosis
  • Negative Result: Suggests absence of known pathogenic variants in tested regions
  • Variant of Uncertain Significance (VUS): Requires additional clinical correlation and family studies
  • Carrier Status: Important for family members and genetic counseling purposes

All results should be discussed with a qualified genetic counselor or specialist to ensure proper interpretation and appropriate medical management.

Test Pricing and Details

Test Component Price (USD)
Discount Price $500
Regular Price $700
Turnaround Time 3-4 Weeks
Sample Type Blood, Extracted DNA, or One Drop Blood on FTA Card

Pre-Test Requirements

Before undergoing the CACNA1D gene test, patients should complete the following:

  • Provide comprehensive clinical history related to primary aldosteronism, seizures, and neurologic symptoms
  • Participate in a genetic counseling session to discuss test implications
  • Complete family pedigree chart documenting affected family members
  • Review test benefits, limitations, and potential outcomes with healthcare provider

Nationwide Testing Availability

We have diagnostic centers conveniently located across the United States, serving patients in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our network ensures accessible genetic testing services nationwide.

Take Control of Your Health Today

Don’t let unexplained symptoms and complex medical conditions go undiagnosed. The CACNA1D gene test provides critical insights that can transform your healthcare journey. Our experienced genetic counselors and medical specialists are ready to guide you through the testing process and help you understand your results.

Book your CACNA1D genetic test today by calling +1(267) 388-9828 or schedule your appointment online. Take the first step toward precise diagnosis and personalized treatment.